SEARCH

SEARCH BY CITATION

References

  • 1
    Memon M et al. Health issues in ethnic minorities: awareness and action. J R Soc of Med 2002; 95: 293295.
  • 2
    Office for National Statistics. Ethnicity and Identity. London: Crown copyright, 2004.
  • 3
    McGarrigle J. Understanding Processes of Ethnic Concentration and Dispersal. Amsterdam: Amsterdam University Press, 2010.
  • 4
    Coleman D. Projections of the ethnic minority populations of the united kingdom 2006–2056. Popul Dev Rev 2010; 36: 441486.
  • 5
    Woodward K , ed. Questioning Identity: Gender, Class, Ethnicity, 2nd edn. London: Routledge/The Open University, 2004.
  • 6
    Blais R, Maïga A. Do ethnic groups use health services like the majority of the population? A study from Quebec Canada. Soc Sci Med 1999; 48: 12371245.
  • 7
    Scheppers E et al. Potential barriers to the use of health services among ethnic minorities: a review. Fam Pract 2006; 23: 325348.
  • 8
    Office for National Statistics. Household Questionnaire. London: Office for National Statistics, 2011.
  • 9
    Centre for Analysis of Social Exclusion. Minority Ethnic Groups in Britain. London: Centre for Analysis of Social Exclusion, 2004. http://sticerd.lse.ac.uk/dps/case/CBCB/census2_part1.pdf (accessed 14 April 2012).
  • 10
    Health and Social Care Information Centre. Health Survey for England 2004: The Health of Minority Ethnic Groups – Headline Tables. London: National Health Service Health and Social Care Information Centre, 2005. http://www.ic.nhs.uk/webfiles/publications/hlthsvyeng2004ethnic/HealthSurveyForEngland161205_PDF%20.pdf (accessed 31 March 2011).
  • 11
    Raleigh V. Diabetes and hypertension in Britain's ethnic minorities: implications for the future of renal services. BMJ 1997; 314: 209213.
  • 12
    Memon M et al. Assessing CHD and hypertension in minority ethnic communities. Nurs Times 2003; 99: 2627.
  • 13
    Department of Health. Choosing Health Through Pharmacy. A programme for pharmaceutical public health 2005–2015. London: Crown copyright, 2005.
  • 14
    Sidi A et al. Medicine related problems in chronic disease: implications for reducing health inequalities. Int J Pharm Pract 2009; 17: B29B30.
  • 15
    Opara N et al. Medicine related problems in South Asian patients living in the UK with chronic illness. Int J Pharm Pract 2010; 18 (Suppl. 2): 9293.
  • 16
    Gordon K et al. The development and validation of a screening tool for the identification of patients experiencing medication-related problems. Int J Pharm Pract 2005; 13: 187193.
  • 17
    Szczepura A. Access to healthcare for ethnic minority populations. Postgrad Med J 2005; 81: 141147.
  • 18
    Kontopantelis E et al. Patient experience of access to primary care: identification of predictors in a national patient survey. BMC Fam Pract 2010; 11: 61.
  • 19
    The King's Fund. Ethnic Health Issues for Primary Care. London: The King's Fund, 2011.
  • 20
    Chan C. A study of health services for the Chinese minority in Manchester. Br J Community Nurs 2000; 5: 140147.
  • 21
    Lip G et al. Ethnic differences in patients perceptions of atrial fibrillation and anticoagulation therapy: the West Birmingham atrial fibrillation project. Stroke 2002; 33: 238242.
  • 22
    Lip G et al. Ethnic differences in patients perceptions of heart failure and treatment: the West Birmingham heart failure project. Heart 2004; 90: 10161019.
  • 23
    Morgan M, Figueroa-Muñoz J. Barriers to uptake and adherence with malaria prophylaxis by the African community in London, England: focus group study. Ethn Health 2005; 10: 355372.
  • 24
    Van Mil JW et al. Drug-related problem classification systems. Ann Pharmacother 2004; 38: 859867.
  • 25
    AbuRuz SM et al. Comprehensive assessment of treatment related problems in hospitalised medicine patients in Jordan. Int J Clin Pharm 2006; 33: 501511.
  • 26
    Harris Y et al. Why African Americans may not be participating in clinical trials. J Natl Med Assoc 1996; 88: 630634.
  • 27
    Rabionet SE et al. A multifaceted mentoring model for minority researchers to address HIV health disparities. Am J Public Health 2009; 99 (Suppl. 1): S65S70.
  • 28
    McDowell S et al. Systematic review and meta-analysis of ethnic differences in risks of adverse reactions to drugs used in cardiovascular medicine. BMJ 2006; 332: 11771181.
  • 29
    Ormerod S et al. Ethnic differences in the risks of adverse reactions to drugs used in the treatment of psychoses and depression: a systematic review and meta-analysis. Drug Saf 2008; 31: 597607.
  • 30
    Tsang C et al. Recording of adverse events in English general practice: analysis of data from electronic patient records. Inform Prim Care 2010; 18: 117124.
  • 31
    Kumar K et al. Beliefs about medicines in patients with rheumatoid arthritis and systemic lupus erythematosus: a comparison between patients of South Asian and white British origin. Rheumatology 2008; 47: 690697.
  • 32
    Wheatly RS, Shelly MP. Drug treatment during Ramadan. Stopping bronchodilator treatment is dangerous. BMJ 1993; 307: 801.
  • 33
    Horne R et al. Medicine in a multi-cultural society: the effect of cultural background on beliefs about medicines. Soc Sci Med 2004; 59: 13071313.
  • 34
    Pardhan S, Mahomed I. Knowledge, self-help and socioeconomic factors in South Asian and Caucasian diabetic patients. Eye 2004; 18: 509513.
  • 35
    Lawton J et al. Perceptions and experiences of taking oral hypoglycaemic agents among people of Pakistani and Indian origin: a qualitative study. BMJ 2005; 330: 1247.
  • 36
    Gordon K et al. Effective chronic disease management: patients' perspectives on medication-related problems. Patient Educ Couns 2007; 65: 407415.